Evidence review
GLP-1 Bloating: Treat the Constipation First, Because That Is the Number That Actually Moved
On the label, measurable bloating barely moves but constipation more than doubles. That changes which problem you should be solving first.
On this page
Start here
Most people treating GLP-1 bloating are treating the wrong thing. Here is what the labels actually report, injection against placebo:
| Symptom | Wegovy 2.4 mg | Zepbound 15 mg |
|---|---|---|
| Constipation | 11% → 24% | 5% → 11% |
| Burping (eructation) | <1% → 7% | 1% → 5% |
| Indigestion | 3% → 9% | 4% → 10% |
| Abdominal distension | 5% → 7% | 2% → 4% |
Two things fall out of that.
Constipation is the big mover — it more than doubles on Wegovy. A slowed bowel produces exactly the pressure, fullness and gas people describe as bloating.
Measurable swelling barely moves. Abdominal distension shifts two points. Most of what you are feeling is not distension the trials could measure.
So: treat the constipation first. It is the largest effect on the label and the most treatable thing on this page.
The dose assumption that is wrong
You will read that everything gets worse as you titrate. Zepbound's own table disagrees:
| Zepbound dose | Constipation | Burping |
|---|---|---|
| 5 mg | 17% | 4% |
| 10 mg | 14% | 5% |
| 15 mg | 11% | 5% |
Constipation falls as the dose rises, and burping plateaus rather than climbing — burping on a GLP-1, by drug sets that out across all four products. If your worst gut weeks were early, that is the expected shape, not a warning about what is coming.
What to do, in order of what the evidence supports
- Fix the constipation properly. Not "eat more fiber" as a gesture — fluid, movement, and an actual conversation with your prescriber or pharmacist about an osmotic laxative if it has been more than a few days. This is the highest-yield action available.
- Don't push through a dose step. Both labels give the same instruction when a dose is not tolerated: consider delaying the escalation — hold, drop, or push through has the exact wording and what to say to get it. If your program makes that hard, the best GLP-1 for busy schedules board scores pausing and canceling. Bloating that arrived with a step and is still there three weeks later is information about pace.
- Cut the carbonation. Fizzy water is what most people switch to when food stops appealing, and it is a direct source of gas.
- Slow the meal down. Swallowed air is a real contributor to burping, and eating fast is what happens standing at a counter between other people's needs.
- Check the magnesium. People often add it for constipation and then develop the opposite problem. If you started magnesium and things changed direction, look there before changing your injection — diarrhea on a GLP-1 has the label rates and the dehydration line to watch.
- Look at the protein source. Whey is a common trigger, and protein shakes are the default fix for a suppressed appetite. Switching the source is a cheap experiment.
What has no evidence behind it
No trials exist of digestive-enzyme supplements, "GLP-1 support" probiotic blends, or detox protocols against GLP-1 bloating. That is not proof they do nothing — it means anyone selling them for this is not citing evidence.
The SIBO question, sized honestly
A 2025 cohort study matched 216,173 adults starting a GLP-1 or dual GLP-1/GIP agonist against the same number on other second-line diabetes drugs and found more confirmed small intestinal bacterial overgrowth: hazard ratio 2.14 (95% CI 1.13–4.07)2.
Now the rates that doubled: 0.177 against 0.083 per 1,000 patient-years — fewer than two diagnoses per ten thousand patient-years. The long-term analysis did not reach significance, and the population was people with type 2 diabetes rather than women taking a GLP-1 for weight2.
Bloating is common. SIBO is rare. The second is not the explanation for the first in most people.
When to stop self-managing and call
- Vomiting food eaten many hours or a day earlier
- Unable to keep fluids down
- Severe pain that does not ease, or that stays in one spot
- Symptoms escalating rather than plateauing after a dose step
- No bowel movement for several days with worsening pain
Gastroparesis is a real if uncommon event with this drug class and now has a full systematic review describing its pattern3. The distinguishing feature is not intensity — it is food coming back up long after it went down. "Stomach paralysis" on a GLP-1 covers what that means before surgery or any sedation.
One honest caveat
A 2024 review in The Lancet Gastroenterology & Hepatology setting out the gastrointestinal effects of these drugs notes how much management guidance rests on clinical experience rather than trial evidence1. That includes most of the list above. The label numbers are solid; the fixes are reasoned.
Frequently asked questions
Why am I so bloated on a GLP-1?
Most likely constipation rather than distension. On the Wegovy label constipation more than doubles, from 11% on placebo to 24% on the drug, while measurable abdominal distension moves only from 5% to 7%. A slowed bowel produces the pressure and fullness people describe as bloating, and it is the most treatable item on the list.
Does GLP-1 bloating get worse at higher doses?
Not according to the labels. Zepbound reports constipation falling as the dose rises — 17% at 5 mg, 14% at 10 mg and 11% at 15 mg — and burping plateauing at 5% rather than climbing. If your worst gut weeks were early, that is the expected shape.
Do digestive enzymes or probiotics help GLP-1 bloating?
There are no trials of digestive-enzyme supplements, GLP-1 support probiotic blends or detox protocols against GLP-1 bloating. That does not prove they do nothing, but anyone selling them to you for this purpose is not citing evidence.
Could my bloating be SIBO?
Very unlikely. A cohort study of 216,173 matched pairs found a hazard ratio of 2.14 for confirmed small intestinal bacterial overgrowth, but the rates being compared were 0.177 against 0.083 per 1,000 patient-years — fewer than two diagnoses per ten thousand patient-years — and the long-term analysis was not statistically significant.
Could the magnesium I took for constipation be causing this?
It is worth checking before you change anything else. Magnesium is commonly added to manage GLP-1 constipation and can push things in the opposite direction. If your symptoms changed direction after you started it, examine that first.
When is bloating on a GLP-1 a reason to call someone?
Vomiting food eaten many hours or a day earlier, being unable to keep fluids down, severe pain that stays in one place, several days without a bowel movement alongside worsening pain, or symptoms that keep escalating rather than settling after a dose increase. The distinguishing feature of the serious version is not how bad it feels but food returning long after it went down.
Where this leaves you
References
- Jalleh RJ, Rayner CK, Hausken T, Jones KL, Camilleri M, Horowitz M (2024). Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions. The Lancet Gastroenterology & Hepatology. https://pubmed.ncbi.nlm.nih.gov/39096914/
- Sun Y, Veccia D, Liu BDX, Tse W, Fass R, Song G (2025). Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with GLP-1 Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis (216,173 matched pairs; absolute rates 0.177 vs 0.083 per 1,000 patient-years). Diagnostics. https://pubmed.ncbi.nlm.nih.gov/40941750/
- Olubodun T, Osundina MA, Soyoye DO, de Oliveira NMB, Olubodun AB, Ogundele OO (2026). Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes. PLoS One. https://pubmed.ncbi.nlm.nih.gov/42594084/
Read this as information, not instructions. WorkingMomRx is educational and never a diagnosis, a treatment plan, or a reason to start or stop a medication. A GLP-1 is a clinical decision — run it past a licensed clinician who knows your history before you act on anything here.
Continue reading
Burping on a GLP-1, by Drug: Wegovy vs Zepbound vs Mounjaro vs Ozempic
Belching is on every GLP-1 label and nobody quotes the rates. Wegovy 7%, Zepbound 4-5%, Mounjaro 3%, Ozempic 1-3% — plus what to do about it.
ReadDiarrhea on a GLP-1: The Rates, the Fixes, and the Line to Watch
Wegovy reports it in 30% of patients, Zepbound up to 23%. What the numbers mean for planning a work week, and the one symptom that changes the answer.
ReadGLP-1 Side-Effect Quick-Fix Reference for Busy Patients
A scannable, cited reference to common GLP-1 side effects — nausea, constipation, reflux, fatigue — each with a fix and a when-to-call-your-doctor line.
Read